Figure 1From: Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects Median overall survival was 90.3% after 5 years respectively 83.3% (10 years) and 67.8% (20 years). Back to article page